Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Trevi Therapeutics Inc (NASDAQ: TRVI) closed at $4.50 in the last session, up 6.13% from day before closing price of $4.24. In other words, the price has increased by $6.13 from its previous closing price. On the day, 2.48 million shares were traded. TRVI stock price reached its highest trading level at $4.57 during the session, while it also had its lowest trading level at $4.17.
Ratios:
We take a closer look at TRVI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.38 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 12, 2024, Reiterated its Buy rating but revised its target price to $7.50 from $6 previously.
On August 30, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $9.Raymond James initiated its Outperform rating on August 30, 2024, with a $9 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 06 ’24 when GOOD JENNIFER L sold 4,219 shares for $3.03 per share. The transaction valued at 12,784 led to the insider holds 213,313 shares of the business.
GOOD JENNIFER L sold 1,840 shares of TRVI for $5,587 on Sep 09 ’24. The President & CEO now owns 213,313 shares after completing the transaction at $3.04 per share. On Sep 05 ’24, another insider, GOOD JENNIFER L, who serves as the President & CEO of the company, sold 40,277 shares for $3.11 each. As a result, the insider received 125,310 and left with 213,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRVI now has a Market Capitalization of 345895616 and an Enterprise Value of 261530608.
Stock Price History:
Over the past 52 weeks, TRVI has reached a high of $4.60, while it has fallen to a 52-week low of $1.26. The 50-Day Moving Average of the stock is 47.51%, while the 200-Day Moving Average is calculated to be 52.22%.
Shares Statistics:
According to the various share statistics, TRVI traded on average about 1.61M shares per day over the past 3-months and 7556450 shares per day over the past 10 days. A total of 75.45M shares are outstanding, with a floating share count of 45.60M. Insiders hold about 40.68% of the company’s shares, while institutions hold 41.08% stake in the company. Shares short for TRVI as of 1732838400 were 1413263 with a Short Ratio of 0.88, compared to 1730332800 on 1716395. Therefore, it implies a Short% of Shares Outstanding of 1413263 and a Short% of Float of 2.8499998.
